All News |

The FDA granted a priority review for a new supplemental Biologics License Application to Keytruda plus concurrent chemoradiotherapy for patients with locally advanced cervical cancer.

Mohs micrographic surgery offered better survival outcomes for patients with early-stage Merkel cell carcinoma, compared with wide local excision.

Living with stage 4 cancer begs reflection. Have I lived my life with purpose? How will I be remembered? Did I do all I wanted to do?

As Teddi Mellencamp reveals more about her cancer diagnosis and Shannen Doherty receives a standing ovation after her stage 4 cancer diagnosis, here’s what is happening in the oncology space this week.

Merkel cell carcinoma made headlines with the death of Jimmy Buffett. It’s rare and dangerous, and cases are becoming more common.

Kathleen Watt, whose treatment for osteosarcoma involved a decade-long process of facial reconstruction, shares her story in the memoir “Rearranged.”

Rachelle’s unexpected departure reminded me I need to express my appreciation to these special, beloved providers now.

After a stem cell donor saved the life of a patient with a rare leukemia, the two finally had a “very emotional” meeting this past spring in New York.

I had dealt with multiple family members with cancer, but didn't think it would happen to me.

Tedopi, a novel lung cancer vaccine, demonstrated improved survival and safety profile, according to preliminary findings from a phase 3 trial.

Stress, anxiety and depression can affect diet and lifestyle behaviors within young adult cancer survivors.

Nine years of Pinktober while living with metastatic breast cancer.

We asked our audience of patients, survivors and caregivers to those with cancer about their feelings on cancer awareness months. Here's what they had to say.

The FDA granted Welireg a priority review after it showed promising outcomes for patients with pretreated advanced renal cell carcinoma.

The treatment combination of Imfinzi plus radiotherapy is “promising” for certain patients with NSCLC, according to preliminary findings from a trial.

“Integrative therapies can be utilized at any point along the cancer spectrum from diagnosis, throughout treatment and into survivorship,” an expert said.

With National Hereditary Cancer Week and National Previvor Day coming up at the end of the month, I sat down to write something about cancer advocacy and being the parent of a previvor.

Women who were previously treated for cancer during childhood with specific chemotherapy have a higher chance of becoming diagnosed with breast cancer.

Reblozyl for anemia in patients with an MDS subset demonstrated positive effects, compared with previous treatments, according to an MDS expert.

Treatment with perioperative Imfinzi plus neoadjuvant chemotherapy may improve surgery outcomes for patients with resectable non-small cell lung cancer.

A new phase 2b/3 trial was approved to study of S-pindolol benzoate to treat cachexia, a wasting disease associated with cancer.

If I could turn back time and speak to my newly diagnosed self, here's what I'd say!

Tanning beds cause an increased risk of skin cancer among young people — especially those who have a family history of skin cancer.

Oftentimes, I find myself realizing that the statistics related to my cancer diagnosis are like an elephant in the room.

Hematopoietic cell transplantation improved survival among high-risk genetic subgroups of patients with myelodysplastic syndrome, a recent study found.

After cancer and chemo, I tell myself all the time that nothing matters more than your health.

As part of its Speaking Out video series, CURE spoke with Hannah-Lise Schofield of the Children’s Hospital of Philadelphia about the psychosocial needs of young patients with cancer and their families as well as how those needs change over time.

As part of its Speaking Out video series, CURE spoke with Bruce L. Levine of the University of Pennsylvania Perelman School of Medicine about advancements in treatments for pediatric cancer.

As part of its Speaking Out video series, CURE spoke Bruce L. Levine of the University of Pennsylvania Perelman School of Medicine about CAR-T cell therapy, what it means for young patients with cancer and what new horizons it has revealed for treatment.